ScoreWhy is vTv Therapeutics, Inc. ?
1
With a growth in Net Sales of INF%, the company declared Outstanding results in Mar 26
- NET SALES(HY) At USD 36.84 MM has Grown at 216,600%
- OPERATING CASH FLOW(Y) Highest at USD -10.03 MM
- ROCE(HY) Highest at 4.6%
2
High Institutional Holdings at 36.11%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.91% over the previous quarter.
3
Market Beating Performance
- The stock has generated a return of 123.33% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to vTv Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is vTv Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
vTv Therapeutics, Inc.
123.33%
1.19
78.95%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-100.00%
EBIT Growth (5y)
-194.88%
EBIT to Interest (avg)
-21.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.91
Sales to Capital Employed (avg)
0.03
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
36.11%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.50
EV to EBIT
-2.20
EV to EBITDA
-2.20
EV to Capital Employed
-2.94
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-48.19%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend35What is working for the Company
NET SALES(HY)
At USD 36.84 MM has Grown at 216,600%
OPERATING CASH FLOW(Y)
Highest at USD -10.03 MM
ROCE(HY)
Highest at 4.6%
RAW MATERIAL COST(Y)
Fallen by -10,000% (YoY
CASH AND EQV(HY)
Highest at USD 187.02 MM
OPERATING PROFIT(Q)
Highest at USD 23.26 MM
PRE-TAX PROFIT(Q)
Highest at USD 24.1 MM
NET PROFIT(Q)
Highest at USD 24.1 MM
EPS(Q)
Highest at USD 1.65
-6What is not working for the Company
INTEREST(9M)
At USD 0.01 MM has Grown at inf%
DEBT-EQUITY RATIO
(HY)
Highest at -109.03 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 0 times
Here's what is working for vTv Therapeutics, Inc.
Net Sales
At USD 36.84 MM has Grown at 216,600%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 24.1 MM has Grown at 410.45%
over average net sales of the previous four periods of USD -7.76 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 24.1 MM has Grown at 457.75%
over average net sales of the previous four periods of USD -6.74 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -10.03 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD 23.26 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 24.1 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 24.1 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 1.65
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 187.02 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -10,000% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for vTv Therapeutics, Inc.
Interest
At USD 0.01 MM has Grown at inf%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debt-Equity Ratio
Highest at -109.03 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 0 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
